Home › Funds › Siren, L.L.C. › BCAX
Siren, L.L.C. position in BCAX
Bicara Therapeutics Inc · Health Care
Siren, L.L.C. reported holding 5,502,970 shares of BCAX (Bicara Therapeutics Inc) in its Q3 2026 13F filing — a position valued at US$102.4M, representing 2.43% of its reported portfolio and ranking #11 among its reported holdings. Siren, L.L.C. has disclosed BCAX holdings in 9 of the last 9 reported quarters, going back to Q3 2024.
Last updated: 2026-11-12 · Source: SEC EDGAR Form 13F-HR
How Siren, L.L.C.'s BCAX position evolved
Siren, L.L.C. first disclosed a stake in BCAX in Q3 2024 at 3,072,827 shares (US$78.3M). The position peaked in Q2 2026 at 5,602,970 shares, worth US$166.4M. Across 9 filings, Siren, L.L.C. increased the stake 3 time(s), trimmed it 2 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 5,502,970 shares valued at US$102.4M — a reduction of -100,000 shares quarter over quarter.. Notable position changes include a 60% increase in Q2 2025 (shares rose 70% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 3.07M | $78.26M | New |
| Q4 2024 | 3.27M | $57.01M | Add |
| Q1 2025 | 3.27M | $42.57M | Hold |
| Q2 2025 | 5.22M | $48.47M | Add |
| Q3 2025 | 5.22M | $82.38M | Hold |
| Q4 2025 | 5.22M | $87.80M | Hold |
| Q1 2026 | 5.80M | $115.42M | Add |
| Q2 2026 | 5.60M | $166.35M | Reduce |
| Q3 2026 | 5.50M | $102.41M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BCAX and 13F data
BCAX (Bicara Therapeutics Inc) is a Health Care company. 54 other funds we track also report a position in BCAX — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$215.4M), Vestal Point Capital, LP (US$155.9M), Deep Track Capital, LP (US$121.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BCAX
- RA CAPITAL MANAGEMENT, L.P. 7.26M sh · $215.43M · Q2 2026
- Vestal Point Capital, LP 5.25M sh · $155.87M · Q2 2026
- Deep Track Capital, LP 4.10M sh · $121.73M · Q2 2026
- TPG GP A, LLC 3.01M sh · $89.38M · Q2 2026
- Red Tree Management, LLC 2.92M sh · $54.35M · Q3 2026
- Omega Fund Management, LLC 1.82M sh · $54.10M · Q2 2026
- Jones Hill Capital LP 892.62K sh · $26.50M · Q2 2026
- ACORN CAPITAL ADVISORS, LLC 643.38K sh · $19.10M · Q2 2026
- Aisling Capital Management LP 568.92K sh · $16.89M · Q2 2026
- Palo Alto Investors LP 550.41K sh · $16.34M · Q2 2026
- Rock Springs Capital Management LP 535.29K sh · $15.89M · Q2 2026
- NAN FUNG TRINITY (HK) Ltd 427.88K sh · $12.70M · Q2 2026
More on Siren, L.L.C.
FAQ
How long has Siren, L.L.C. held BCAX?
Siren, L.L.C. has disclosed BCAX holdings in 9 of the last 9 reported quarters, going back to Q3 2024.
What is Siren, L.L.C.'s current position in BCAX?
As of Q3 2026, Siren, L.L.C. holds 5.50M shares of BCAX (Bicara Therapeutics Inc), valued at $102.41M, representing 2.43% of its reported portfolio and ranking #11.
Has Siren, L.L.C. been buying or selling BCAX?
In the latest 13F filing (Q3 2026), Siren, L.L.C. reduced its position in BCAX. The position peaked in Q2 2026 at 5.60M shares.
Which other funds hold BCAX?
Other major institutional holders of BCAX include RA CAPITAL MANAGEMENT, L.P., Vestal Point Capital, LP, Deep Track Capital, LP, among 54 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.